Lionco Pharmaceutical Group Co., Ltd., together with its subsidiaries, researches, develops, produces, and sells pharmaceuticals in China. The company offers nutrition, antimicrobial, antiviral, digestion, cardiovascular, detoxification, anti-tumor, and other products. It also operates research institutes that specialize in the research of chemical drugs, natural medicines, and biological drugs. Lionco Pharmaceutical Group Co., Ltd. was founded in 2003 and is based in Shannan, China.

Company Data

Name Lionco Pharmaceutical Group Co.,Ltd.

Company Lionco Pharmaceutical Group Co.,Ltd.

Website https://www.lingkang.com.cn

Primary Exchange

SSE

ISIN CNE1000022R8

Asset Class Share

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

CEO Ling Ping Tao

Market Capitalization 4 Mrd.

Country China

Currency CNY

Employees 0,4 T

Address Commercial and Residential Building 2, 856000 Shannan

IPO Date 2015-05-28

Ticker Symbols

Name	Symbol
SSE	603669.SS

More Shares

Investors who hold Lionco Pharmaceutical Group Co.,Ltd. also have the following shares in their portfolio:

LB.HESS.THR.IS.06A/23 Bond

ONEOK INC19/49 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog